The thymus plays a central role in self-tolerance, partly by eliminating precursors with a T cell receptor (TCR) that binds strongly to self-antigens. However, the generation of self-agonist-selected lineages also relies on strong TCR signaling. How thymocytes discriminate between these opposite outcomes remains elusive. Here, we identified a human agonist-selected PD-1 +
INTRODUCTION
The generation of a diverse T cell receptor  (TCR) repertoire in the thymus is crucial for protection against foreign antigens, but, at the same time, thymocytes expressing a TCR with strong affinity for self-antigens must be prevented from exiting the thymus as naïve T cells. Successful rearrangements of TCR chains are therefore subjected to checkpoints where strength of TCR signaling will determine lineage outcome (1, 2) . Most of the mature TCR + cells generated in the thymus display low affinity for self-peptide major histocompatibility complexes (MHCs) and exit the thymus as naïve CD4 or CD8 single-positive T cells (2) . Developing thymocytes with a rearranged TCR that reacts strongly with self-peptide MHCs could cause severe autoimmunity if they are allowed to enter the conventional naïve T cell pool.
Not all autoreactive immature thymocytes are deleted by conventional negative selection. Alternatively, they can be specifically preserved and adopt distinct functional fates when developing along the agonist selection path (3, 4) . Agonist-selected T cells, such as double-negative (DN) intraepithelial T cells (IETs) and the natural killer T (NKT) cells, are predominantly tissue-resident cells that display a full effector phenotype marked by the expression of natural killer (NK) receptors and cytotoxic effector molecules such as granzyme and Fas ligand (5, 6) . These cells are typically restricted by unconventional MHCs (7) , which, together with their innate functional phenotype, suggests that agonist-selected T cells have nonredundant immunological functions and may be regulated differently from conventional MHC-restricted CD8 + and CD4 + TCR + subsets.
It is unclear how strong TCR activation in preselection thymocytes can lead to such divergent outcomes as apoptosis or agonistselected maturation. Some studies suggested that the intensity of TCR signaling could lead to differential induction of apoptosis mediators, thereby creating a threshold for clonal deletion (8, 9 ). An alternative suggestion was that CD28 costimulation controlled the outcome of strong TCR signaling in T cell precursors because, in the absence of CD28, more agonist-selected DN T cells are generated (10) . However, the proposed mechanisms imply that a single progenitor T cell dies by apoptosis or matures to a functional T cell depending on the nature of the (co)stimulus. Alternatively, these cell types may have different precursors because a preselection subset of T cell progenitors in mice was found to specifically give rise to DN T cells (11) . This subset is characterized by expression of CD4, CD8, and CD8 [triplepositive (TP)] and a low level of TCR, suggesting that these are early post--selection precursor cells. Last, studies in transgenic mice have shown that the development of agonist-selected DN TCR + cells is favored when a pre-rearranged transgenic TCR with high affinity for a cognate self-antigen is expressed "prematurely" before conventional selection at the double-positive (DP) stage, indicating that the timing of TCR rearrangement also influences the outcome of selection (12, 13) .
Natural TCR rearrangements occur in an ordered sequence, with TCR, TCR, and TCR being the first TCR genes to undergo rearrangement. If a functional TCR chain is generated, then it will associate with an invariant pT chain, and signaling through this pre-TCR complex induces proliferation and developmental progression, a process called -selection. The phenotypical stage at which -selection occurs differs between murine and human thymocytes. Although TCR is first expressed at the CD4 and CD8 DN stages in murine T cell precursors, human thymocytes rearrange the TCR chain at the CD4 immature single-positive stage (CD4ISP). Pre-TCR-signaled CD4ISP cells are large cycling cells, have up-regulated expression of CD28, and enter the CD4 and CD8 DP stages as large, metabolically active CD4 hi DP cells (14) (15) (16) . In both human and murine thymus, most of the DP precursors are small resting cells with ongoing TCR rearrangements. Most TCR rearrangements are found late at the DP stage, but some reports have identified TCR transcripts at earlier stages as well (17, 18) .
Here, we identified a population of mature programmed cell death protein-1 (PD-1)-and CD8-expressing TCR + T lymphocytes (6) (7) (8) 19 ) that exhibits innate production of interferon- (IFN-) and expresses Homolog of Blimp-1 in T cells (Hobit), a transcription factor (TF) recently identified as a hallmark TF of tissue-resident effector memory cells and innate T cell subsets (20) . We show that the TCR repertoire of this population is skewed for early TRAV and TRAJ rearrangements. The data show that different preselection precursors give rise to either agonist-selected or conventionally selected T cells and that the checkpoint in the thymus to divert immature thymocytes to the agonist selection pathway occurs before conventional selection.
RESULTS

Identification of a PD-1
+ CD8 + T cell population in the human thymus and cord blood To identify an in vivo equivalent of agonist-selected T cells, which, as we previously showed, can be generated in vitro in an OP9-DL1 culture system (21, 22) , we analyzed human postnatal thymocytes ex vivo for expression of PD-1, a recently described marker for agonist selection (7, 8, 10) . Expression of CD10, a marker for common lymphoid and more mature B and T cell precursors (23) , was lost during thymocyte differentiation but remained selectively expressed on mature PD-1 + thymocytes. Many of the TCR + thymocytes express both CD10 and PD-1 (Fig. 1A and fig. S1 ). However, a population of CD10 (Fig. 1B) . The PD-1 + CD8 + TCR + population was present in all thymus and cord blood samples analyzed at a frequency comparable to that of the TCR + population (Fig. 1C and tables S1 and S2). Furthermore, we detected a similar CD3 low PD-1 + population among naïve CD45RO − CD8 T cells in peripheral blood of young children ( fig. S4) but not of adults. In addition to PD-1, the activation marker CD8 has also been associated with agonist selection (6, 10, 11) . Therefore, we next assessed expression of CD8 by thymus leukemia antigen (TL)-tetramer binding (24) and found that PD-1 + CD8
+ TCR + cells from the thymus and cord blood stained homogeneously with TL tetramer, indicating that they coexpressed CD8 homodimers together with CD8 heterodimers (Fig. 1D) . Consistent with this finding, PD-1 + TCR + cells stained weaker with anti-CD8 antibody as compared with CD8 antibody (Fig. 1E) . Together, these data indicate that, in the CD8 + TCR + T cell population in the human thymus and cord blood, there is a distinct subset of cells that express PD-1 and CD8, both hallmarks of agonistselected cells. Furthermore, these CD8 + PD-1 + TCR + cells express high levels of CXCR3 typically associated with effector and tissue-resident memory T cells (25) but low levels of CD62L and CCR7, which mark naïve T cells in lymphoid tissues (Fig. 1F ) (26 (Fig. 2C) confirmed the distinct signature in CD8 − and CD8 + T cells and identified Hobit as one of the most differentially expressed genes that distinguishes the two subsets. Hobit was expressed by thymus-and cord blood-derived CD8 + T cells, and this was confirmed by quantitative polymerase chain reaction (qPCR) (Fig. 2D) . Hobit was recently identified as a hallmark TF expressed by tissue-resident effector memory cells and functionally differentiated innate cells including agonistselected NKT and liver-resident NK cells (20) . Furthermore, a Gene Set Enrichment Analysis (GSEA) on the human conventional CD8 − versus the innate CD8 + T cells revealed that CD8 + T cells were enriched for those genes that were also associated with the Hobit-expressing cells in mice (Fig. 2E) (20) . These data indicate that the CD8 + T cells identified in humans have already functionally differentiated and activated a transcriptional program for tissue residency shortly after their generation in the thymus. In contrast, CD8 − T cells express CCR7 and CD62L, typically associated with a naïve and lymph node-homing phenotype (Fig. 2C ). NELL2 and LRRN3 are genes that are induced after positive selection (22, 27) and remain highly expressed in naïve TCR + cells. Accordingly, these genes are not induced in the CD8 + subset, supporting the notion that these T cells are derived via a mechanism that is distinct from conventional positive selection (Fig. 2, F Fig. 3A and fig. S7 ). In addition, IL-15-responsive CD8 + cells induced the NK cell-associated receptor CD56, which is characteristic of cytotoxic effector cells (29) . In contrast, CD56 induction was limited on the responding CD8 − T cells ( fig. S7 ). Next, we tested the TCR-driven proliferation of cord blood CD8 − and CD8 + T cells. CD3/CD28 costimulation of the naïve CD8 − T cells induced marked proliferation after 5 days of culture in the absence of exogenous common -chain cytokines (Fig. 3B) . In contrast, CD3/CD28 costimulation of the already-activated CD8 + T cells led to cell death in the absence of cytokines. Addition of cytokines, especially IL-15, led to enhanced survival on day 2 and marked proliferation on day 5 ( fig. S8 ).
To assess whether CD8 + T cells, similar to innate T cells, also display immediate effector functions, we measured IFN- production after 6 and 24 hours of stimulation in vitro. Consistent with an innatelike effector profile, CD8 + T cells responded rapidly to stimulation and produced significantly higher amounts of IFN- after 6 and 24 hours of in vitro stimulation as compared with their CD8 − or CD4 + counterpart (Fig. 3C) . In further agreement with their innate effector phenotype, CD8 + T cells also expressed a typical CD8 effector TF profile with high expression of T-bet but low FOXO1 expression (Fig. 3D) . In contrast, CD8 − T cells isolated from cord blood expressed high levels of FOXO1 but not of T-bet (Fig. 3D ).
CD8
+ T cells express hallmarks of agonist-selected cells To examine whether the innate functional effector phenotype expressed by the mature CD8 + T cells might have been imprinted during the selection process in response to self-antigen recognition, we next analyzed the expression of a set of genes that have been associated with post-agonist-selected CD8 + T cells in mice (6) . GSEA on CD8
− and CD8 + T cells showed an enrichment in human CD8 + thymocytes for transcripts of genes associated with agonist selection, and this enrichment became even more pronounced in the more mature cord blood CD8 + T cells (Fig. 4A ). The agonistselected nature of CD8 + T cells was further supported by high levels of Helios, a TF induced upon strong TCR stimulation (30, 31) . Despite an association with strong TCR signals, CD8 + T cells expressed significantly lower levels of the clonal deletion-associated genes Bim and Ian1 ( 
CD8 expression on early post--selection thymocytes marks a distinct precursor subset
In mice, TP thymocytes that coexpress CD8, together with CD8 and CD4, can survive strong TCR signals and differentiate into mature DN or CD8 + T cells (11) . To examine whether a similar subset exists among human DP thymocytes, we stained with TL tetramer and found that CD8 expression marks large early post--selection DP precursors similar to the CD4 hi DP population previously described ( Fig. 5A) (16) . In addition to CD8, these thymocytes also express PD-1 and CD28, both markers induced by pre-TCR signaling ( Fig. 5B ) (14, 15, 33, 34) . Together, these observations indicate that, among the DP progenitors, the expression of CD8, PD-1, and CD28 marks a subset that we will refer to as TP blasts. This population is distinct from Paired sample t test (two-tailed); P value is shown; n = 5. Error bars represent SD.
the vast majority of DP thymocytes that constitute the "DP small" subset and do not coexpress CD8, PD-1, and CD28 ( Fig. 5 , A and B). In addition, the expression level of several hallmark genes associated with DP thymocytes is in agreement with the notion that the TP blast and DP small populations represent early and late post--selection stages ( fig. S9 ) (35) .
To test whether early post--selection progenitors have a higher potential to survive strong TCR signals associated with agonist selection, we compared the differentiation potential of TP blast and DP small along with CD4ISP as the most immature post--selection population identified in humans. We stimulated these preselection populations with anti-CD3 and monitored their ability to mature into postselection T cells. Although unstimulated populations survive rather well in culture ( fig. S10 ), stimulation with a high dose of anti-CD3 resulted in the death of virtually all TCR + DP small cells, whereas TCR + progeny of the stimulated CD4ISP and TP blast survived (Fig. 5C ). The surviving anti-CD3-stimulated thymocytes up-regulated the maturation marker CD27, down-regulated CD4 expression but remained CD8 + (Fig. 5C ), and expressed high levels of the activation markers PD-1 and CD8 (Fig. 5D ) similar to the CD8 + T cells isolated ex vivo from the human thymus and cord blood. Mature TCR + cells generated from CD4ISP precursors also expressed CD8, suggesting that precursors developed along a DP intermediate before rearranging a TCR chain that allows agonist selection. TCR + DP precursors were already present after 3 days of in vitro culture of CD4ISP (fig. S11). CD4ISP and TP blast not only survived strong TCR stimulation but also proliferated ( fig. S12 ). In Fig. 5E , we corrected for differential proliferation as well as for the differential degree of rearranged TCR + cells between the three populations ( fig. S11 ) to calculate the agonist selection potential of each progenitor population. This shows the loss in agonist selection potential as the precursor population progresses from early to late post--selection.
Early TCR rearrangements favor development of agonist selectionassociated innate CD8 + T cells To investigate whether the footprint of agonist selection is reflected in the human postselection TCR repertoire, we determined the TCR rearrangements in mature Up-regulated genes Down-regulated genes S6 for the list of genes). (F) Confirmatory RT-PCR analysis for LRRN3 and NELL2 transcripts in populations as defined in (A), expressed in AU relative to expression in the total postnatal human thymus. P value is shown; paired sample t test on log-transformed values (two-tailed); n = 3. Error bars represent SD.
ex vivo-isolated conventional CD8 − and agonist selection-associated CD8 + thymocytes. Because it is known that human TCR rearrangements occur sequentially in time from J-proximal to J-distal for the TRAV gene segments and from V-proximal to V-distal for the TRAJ gene segments, we analyzed TCRV and J usage for both populations (Fig. 6A, figs . S13 and S14, and table S4). Next-generation sequencing (NGS) of TCR transcripts was performed on both populations of four donors and revealed that the agonist selection-associated CD8 + T cells preferentially use early J-proximal TCRV rearrangements (TRAV41-TRAV40-…), whereas conventional positively selected CD8
− T cells contained a relatively higher frequency of late J-distal TRAV1-1 and TRAV1-2 gene segments: Evaluation of the distribution of all TRAV and TRAJ genes showed a significant enrichment for early rearrangements in CD8 + T cells as evidenced by a Spearman correlation coefficient of >0 for the V gene segment usage and a Spearman correlation coefficient of <0 for the J gene segment usage. This pattern was also observed in post-thymic cord blood CD8 + T cells, as assessed by microarray expression analysis ( fig. S14) . To investigate at what point the repertoire imprinting occurred during development, we analyzed TCR rearrangements of the TP blast and DP small thymocyte subsets. We identified the same bias for early TCRV and J usage in the TP blasts when compared with the DP small precursor cells (Fig. 6B) . These findings constitute strong evidence for the concept that the developmental stage of the precursor at which the TCR rearrangements occur, allowing for the expression of the full TCR, plays a decisive role in determining the fate of the maturing thymocytes in response to strong agonist selection signals.
In addition to the differential timing for TCR rearrangements, we observed that TCR transcripts were also differentially expressed in CD8 + and CD8 − T cells. As demonstrated by qPCR for TRGC and microarray analysis for the different TRGV, TRGJ, and TRGC transcripts, CD8 + T cells do not silence TCR transcripts as conventional T cells do (Fig. 6, C and D) . A similar high level of TCR expression was previously described for agonist selectionassociated innate T cells in mice, including NKT and intestinal epithelial CD8 + T cells (36) . Together, we conclude that human ) T cells from the human postnatal thymus, expressed in AU relative to expression in the total postnatal human thymus. P value is shown; paired sample t test on log-transformed values (two-tailed); n = 3. Error bars represent SD.
CD8
+ T cells are preferentially selected by strong TCR engagement on a subset of progenitors that express a full TCR early on, leading to the generation of a postselection T cell pop ulation with innate functional capacity and a markedly distinct TCR repertoire.
DISCUSSION
Strong TCR signals result in the elimination of self-reactive thymocytes by clonal deletion or the induction of a specialized functional program characteristic of agonist-selected T cells. The mechanisms underlying the different outcomes of strong TCR activation on thymocytes are still poorly understood. We characterized an agonist-selected T cell population in humans that expresses CD8 homodimers. Thymic selection of this subset induces an innate effector phenotype hallmarked by the expression of a Hobit-associated gene expression profile. This study's main finding is that early TCR rearrangements favor the generation of this lineage in an unmanipulated setting in humans, indicating that the checkpoint in the thymus to divert immature thymocytes to the agonist selection pathway occurs early before conventional selection of DP cells. Human CD8 + T cells are present in the thymus, cord blood, and peripheral blood of young children but not of adults. This suggests that this innate T cell population is mainly generated early in life but does not remain present in the circulation thereafter. In contrast, CD8 + T cells are found in adult human small intestinal epithelium and liver and, similar to thymic CD8 + T cells, lack expression for NELL2. The ability of the CD8 + T cells to home to the tissues seems to be acquired at the time of agonist selection because Hobit is sharply upregulated in the thymic CD8 + T cells. Hobit is a Blimp-1 homolog that is expressed in long-lived resident effector memory T cells that combine long-term quiescent maintenance with the immediate capacity to induce effector molecules (20, 37, 38) . Such a functional program makes these cells ideally equipped for immunosurveillance in the tissues as has been suggested for both murine DN T cells and human CD8 + tissue-resident T cells in several models of infection (39) (40) (41) (42) ). An important role in tumor immunosurveillance was recently described for murine innate lymphoid cells and innate-like T cells that are composed of both TCR + and TCR + cells with similar functional properties (43) . Furthermore, murine DN TCR + cells can recognize peptides processed in a TAP (transporter associated with antigen processing)-independent fashion or by nonclassical MHC molecules, suggesting that these cells are designed to target cells when conventional antigen processing or presentation is impaired, such as viral infection or cellular transformation (7) .
The differential TCR usage between agonist-selected and conventional T cells reveals that the decision of agonist-selected differentiation or apoptosis upon strong TCR stimulation is based on the timing and developmental stage at which a complete TCR complex TRAV gene locus   TRAV41  TRAV1-1  TRAV35  TRAV26-1  TRAV20  TRAV12-3  TRAV13-1  TRAV6   5'  3'   TRAJ gene locus   TRAJ3  TRAJ57  TRAJ18  TRAJ27  TRAJ34  TRAJ42 TRAV gene locus
TRAJ gene locus TRAJ3  TRAJ57  TRAJ18  TRAJ27  TRAJ34  TRAJ42  TRAJ49 Th   TRGV1  TRGV2  TRGV3  TRGV4  TRGV5  TRGV8  TRGV9  TRGV10  TRGV11  TRGJ2  TRGC1  TRGJP1 engages its ligand. We showed evidence that only early CD4ISP or TP blasts survive strong TCR activation, whereas small DPs undergo apoptosis. Alternatively, small DPs represent the main precursor population of conventionally selected cells because small DPs are more enriched for late-rearranging TRAVs and TRAJs. Our findings link several observations made in TCR transgenic and wild-type mice. First, a prominent DN T cell population is generated upon cognate TCR ligand interactions in TCR transgenic mice, and this phenomenon has been attributed to premature expression of the transgenic TCR chain (12) . Also, in non-TCR transgenic mice, thymocytes with extremely early spontaneous TCR rearrangements at pre-DP stages preferentially give rise to T cells that accumulate in the small intestinal epithelium (44) . However, lineage fate-mapping showed that CD8 + IETs arise from RORt + precursors, suggesting a DP intermediate (45) . Such an intermediate population was identified by Gangadharan et al. (11) as CD8 + DPs or TPs and confirmed to be the direct progenitors of agonist-selected T cells in mice. Here, our findings unite these previous observations and define TP thymocyte precursors as early post--selection blasts that express an early rearranged TCR repertoire that is maintained in the repertoire of postselection CD8 + T cells and is different from that of conventionally selected T cells.
Last, we found that TP blast and small DP thymocytes not only differ in the pattern of TCR rearrangements but also respond differently to strong TCR signaling. It has been shown that CD8 induction on strongly activated conventional CD8 + T cells can mediate their selective survival and differentiation into effector memory T cells that preferentially accumulate in peripheral tissues (46) . Activationinduced CD8 expression not only could dampen TCR signaling and disrupt lipid rafts but also could potentially sequester or redirect lymphocyte-specific protein tyrosine kinase (p56lck) and linker for activation of T cells (LAT) toward other receptors located outside the rafts, such as IL-15R (19) . We found that what enables TP blasts to survive strong TCR activation and avoid expression of Bim is not only the down-modulation of the TCR signal because the levels of Bim expression in agonist-selected cells are unexpectedly low compared with those in the weakly signaled conventional thymocytes. Alternatively, the ability to up-regulate Bim upon strong TCR activation could be a property absent in early thymocytes and acquired during progression to small DP stages.
Our data demonstrate that the checkpoint for agonist selection precedes conventional selection in the human thymus. Analysis of the TCR repertoire provides a useful tool in studying human T cell development because it naturally reflects developmental progression where genetic manipulations are not possible. However, it does not detect at what point during thymic development the deviation occurs, nor does it provide insight into the mechanisms that mediate this early deviation.
During thymic development, there is a phase immediately after -selection where TCR rearrangement and expression of a full TCR early on deviate precursors to develop along the agonist selection pathway and to functionally differentiate to innate-like T cells in response to strong agonist selection signals. In contrast, precursors that undergo E-protein-mediated progression to late DP stages (47) are destined to be either positively selected as stem cell-like naïve conventional T cells (48) or deleted in response to strong TCR signals during conventional negative selection. It is currently not yet clear which molecular processes determine the onset and timing of TCR rearrangements at the single-cell level. However, it was shown that this regulation is distinct from that of DP progression, because only the up-regulation of RORt (retinoic acid receptor-related orphan nuclear receptor t) but not the onset of TCR rearrangement is dependent on proliferation and expression of Myc (49) . Recent work has suggested that heterogeneity among DPs could be introduced at the pre-TCR checkpoint because some pre-TCR complexes can interact with thymic ligands, and this interaction was shown to enhance pre-TCR signaling (50) . The current findings turn the spotlight on early developmental stages as a critical checkpoint in selfreactive T cell development and present agonist selection as an instructed program rather than the result of an escape from negative selection.
MATERIALS AND METHODS
Study design
This study was initiated to identify agonist-selected T cells in human thymus, peripheral blood, and tissues as well as to gain insight into their developmental pathways. Human postnatal thymus was obtained from children (0 to 8 years old) who underwent cardiac surgery, and cord blood was obtained from healthy donors. These cells were used following the guidelines of the Medical Ethical Committee of Ghent University Hospital after informed consent had been obtained in accordance with the Declaration of Helsinki. For the purpose of phenotypical characterization, 8 donors were used for thymic samples and 27 donors were used for cord blood samples because these numbers reflect the availability of both samples throughout the time frame of the study. For the microarray analysis, three donors were used for both thymus and cord blood samples and mixed in an effort to increase RNA yield and minimize bias caused by interdonor variability. For the TRA NGS, four donors were used and individually analyzed for TRA sequence because the assay was technically achievable with lower RNA yields when compared with microarray analysis. Peripheral blood of young children (1 to 2 years old; six donors), adult liver (three donors), or adult small intestine (one donor) was obtained according to the national legislation concerning the use of human rest material, and ethical approval was obtained from the Medical Ethical Committee of Ghent University Hospital. The number of donors reflects the availability of the samples throughout the time frame of the study. The study was unblinded and not randomized.
Cells and purification
CD8
+ and CD8 + T cells were isolated from the postnatal thymus after previous depletion of CD4 + fractions using fluorescein isothiocyanate (FITC)-conjugated mouse anti-human CD4 antibodies (OKT4) in combination with sheep anti-mouse immunoglobulin G-coated Dynabeads (Life Technologies). TCR + cells were isolated from the postnatal thymus by anti-TCR magnetic-activated cell sorting (Miltenyi Biotec). CD8 + and CD8 + T cells were isolated from cord blood after previous enrichment with biotin-conjugated anti-CD8 antibodies (OKT8) in combination with streptavidin microbeads (Miltenyi Biotec). The obtained cell population was subsequently labeled with fluorochrome-conjugated antibodies according to the experimental design and sorted with a fluorescence-activated cell sorting (FACS) Aria II (BD Biosciences).
Isolation of IET from human small intestine
Human ileum was obtained from a patient who underwent right hemicolectomy. The ileum was dissected from the colon and cut into 1-to 5-mm 2 pieces. Intraepithelial cells were isolated by incubation in isolation buffer [Iscove's modified Dulbecco's medium, 10% fetal calf serum (FCS), 1 mM EDTA, and 1 mM dithiothreitol] during mechanical rotation at 37°C for 20 min. This isolation step was performed twice, and isolated cells in suspension were next subjected to Percoll centrifugation (44 and 67% Percoll) at 1800 revolutions per minute (rpm) for 20 min to purify the lymphocytic fraction.
Isolation of liver T cells
Human liver samples were obtained from patients who underwent partial hepatectomy. The healthy liver tissue was dissected and cut into 1-to 5-mm 2 pieces. Liver-resident cells were enzymatically isolated [collagenase (0.5 mg/ml), deoxyribonuclease (0.02 mg/ml), 2% FCS, and 0.6% bovine serum albumin (BSA) in Hanks' balanced salt solution] at 37°C for 20 min. Isolated cells in suspension were next subjected to Percoll centrifugation (30 and 70% Percoll) at 1800 rpm for 20 min to purify the lymphocytic fraction.
Flow cytometry and antibodies
The following anti-human monoclonal antibodies were used: FITCconjugated CD4 and TCR (BD Biosciences); phycoerythrin (PE)-conjugated PD-1 and TCR (Miltenyi Biotec); CD62L and CCR7 (BD Pharmingen); CD28 (BD Biosciences); PE-cy7-conjugated CD8 (eBioscience); CD10 (BD Biosciences); allophycocyanin (APC)-conjugated CD3, CD5, CD8, and CD56 (BD Biosciences); TCR (Miltenyi Biotec); CXCR3 (BioLegend), APC-cy7-conjugated CD3 and CD27 (eBioscience); CD8 (BD Biosciences); eFluor 450-conjugated CD1a (eBioscience); Alexa Fluor 700-conjugated CD4 (BD Pharmingen); biotin-conjugated PD-1 (Miltenyi Biotec); and peridinin chlorophyllcy5.5-conjugated streptavidin (eBioscience). CD8 expression was assessed by staining with PE-conjugated TL tetramer (provided by H.C.) after previous staining with anti-CD8 antibodies. Annexin V Apoptosis Detection Kit APC (eBioscience) was used for quantification of apoptosis. Flow cytometric analysis was performed using an LSR II cytometer (BD Biosciences).
Real-time qPCR
Total RNA was prepared from FACS-sorted samples using the miRNeasy Micro Kit (Qiagen). Complementary DNA (cDNA) synthesis was performed by the SuperScript III Reverse Transcriptase for reverse transcription polymerase chain reaction (RT-PCR) kit (Invitrogen). RT-qPCR with the SYBR Green I technology was performed using the LightCycler 480 SYBR Green I Master kit on a LightCycler 480 II (both from Roche) according to the manufacturer's protocol. Primer sequences (Integrated DNA Technologies, Heverlee, Belgium) are listed in table S5. Primers for Ian1 (alias Gimap4) were purchased from Bio-Rad.
T cell stimulation and IFN- ELISA
For enzyme-linked immunosorbent assay (ELISA), 20 × 10 3 to 50 × 10 3 cells were stimulated for 6 and 24 hours with phorbol 12-myristate 13-acetate (PMA) (60 ng/ml) and ionomycin (6 g/ml), followed by collection of 50 l of supernatant. ELISA was performed according to the manufacturer's protocol using the PeliPair human IFN- ELISA reagent set and the PeliKine-Tool set (Sanquin, Amsterdam, Netherlands) in 96-well half-area ELISA plates (Greiner Bio-One, Wemmel, Belgium).
CellTrace proliferation assay
Cells were labeled with the CellTrace Violet Cell Proliferation Kit (Invitrogen) following the standard method for labeling cells in suspension as described by the manufacturer.
Microarray RNA expression analysis RNA was isolated using the micro-RNA isolation kit (Qiagen) and sent to the Nucleomics facility, VIB Leuven, Belgium, where the microarrays were performed using the GeneChip Human Gene 2.0 ST arrays (Affymetrix). Samples were subsequently analyzed using R/Bioconductor. All samples passed quality control, and the robust multiarray average procedure was used to normalize data within arrays (probe set summarization, background correction, and log 2 transformation) and between arrays (quantile normalization). Only probe sets that mapped uniquely to one gene were kept, and, for each gene, the probe set with the highest expression level was kept. Because of the high stringency of this method, some genes of interest were lost. These genes were added manually, as long as one probe set is linked to only one gene of interest.
TCR NGS
RNA was isolated from sorted (50,000 to 1 million cells) thymocyte subsets with the RNeasy Micro Kit (Qiagen) followed by template-switch anchored RT-PCR (51, 52) . More specifically, a template-switch adaptor, 5′-AAGCAGTGGTATCAACGCAGAGTACATrGrGrG-3′, was ligated at the 5′ end of mRNA during cDNA generation using the SuperScript II RT enzyme (Invitrogen). The cDNA product was purified using AMPure XP Beads (Agencourt). Then, PCR amplification (LightCycler, Roche) was performed using a C-specific primer containing an adapter used in subsequent sequencing (5′-GTCTC-GTGGGCTCGGAGATGTGTATAAGAGACAGTCTCAGCTGGTACACG-GCAGGGTCAGGGT-3′; adapter in italic) and a primer complementary to the template-switch adapter (5′-TCGTCGGCAGCGTCAGATGTG-TATAAGAGACAGAAGCAGTGGTATCAACGCAG-3′; adapter in italic) with the KAPA Real-Time Library Amplification Kit (Kapa Biosystems). The PCR was stopped when the amplified PCR product, as measured with SYBR Green, was within standards 2 and 3. After purification with AMPure XP beads, an index PCR with Illumina sequencing adapters was performed using the Nextera XT Index Kit. This second PCR product was again purified with AMPure XP beads. High-throughput sequencing of the generated amplicon products containing the TRA sequences was performed on an Illumina MiSeq platform using the V2 300 kit, with 200 base pairs (bp) at the 3′ end (read 2) and 100 bp at the 5′ end (read 1) [at the GIGA (Grappe Interdisciplinaire de Génoprotéomique Appliquée) center, University of Liège, Belgium]. The percentages of V and J usage of each thymocyte subset were obtained after analysis of the FASTAQ files (read 2) with the MiTCR software (53) using the default settings for the correction level (level 2) and quality threshold values (PHRED value of 25). The ratio of the percentage of V and J usage in thymocyte populations was determined, and 0.00625% was added to the calculated percentage of each TRAV or TRAJ gene (which corresponds to about 0.5 sequence counts) to avoid division by "0."
In vitro TCR agonist selection Cells (10 5 ) of thymic precursor populations were cultured for 3 days in the presence of IL-7 (10 ng/ml) and IL-15 (10 ng/ml) on BSA-or anti-CD3 (10 g/ml)-coated wells of 96-well plates. After 3 days, cells were washed and cultured in the absence of anti-CD3 stimulation in U-bottom 96-well plates in the presence of IL-7 (10 ng/ml) and IL-15 (10 ng/ml) for another 3 days to allow reexpression of the TCR complex before flow cytometric analysis. To determine the agonist selection potential of each progenitor population, we calculated the ratio of mature TCR + cells present on D6 to the total number of TCR + cells present or generated in each culture during the first 3 days of culture that cells have the opportunity to be activated by plastic-coated anti-CD3 (7% TCR + cells for CD4ISP, 44% TCR + cells for TP blast, and 66% TCR + cells for DP small). This number is corrected for the level of proliferation in each culture as determined by FlowJo software in a separate proliferation assay using CellTrace Violet dilution.
Statistical analysis
Student's t tests and paired sample t tests (two-tailed) were performed using SPSS software. For RT-qPCR experiments, the mean of duplicates from different donor samples were first log-transformed before performing paired sample t tests (two-tailed) across different donor samples using SPSS software. GSEA was performed using the GSEA tool v2.2.2 of the Broad Institute (http://software.broadinstitute.org/ gsea/index.jsp). The "GSEAPreranked" module was run using standard parameters and 1000 permutations. Different gene sets (grp extension), preranked lists (rnk extension), and the chip annotation file were uploaded. For analysis of TRAV and TRAJ usage, 44 TRAV genes and 51 TRAJ genes were ranked according to their location within the TRA locus (1 to 44 for TRAV and 1 to 51 for TRAJ), and ranked Spearman correlation coefficients as well as corresponding P values were calculated on log-transformed values of ratios corresponding to a single TRAV or TRAJ gene using SPSS software.
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